Recombinant Cynomolgus CD6 Protein(HEK293), Avi & His

Langerin, also known as CD207, is a C-type lectin receptor predominantly expressed on Langerhans cells, a specialized subset of dendritic cells found in the epidermis. This receptor plays a critical role in the immune response by mediating the recognition and internalization of pathogens, such as viruses and bacteria, through its carbohydrate-binding activity. Due to its unique properties, Langerin is important for maintaining skin immune surveillance and tolerance. Research on recombinant Langerin/CD207 protein has gained importance for several reasons. First, understanding its structure and function can offer insights into the mechanisms of antigen presentation and T cell activation, crucial for developing novel immunotherapies. Additionally, Langerin's ability to bind to specific glycans makes it a potential target for vaccine development and targeted drug delivery systems. Studies involving recombinant Langerin also pave the way for exploring its role in various skin-related diseases, including infections, allergies, and autoimmune disorders. Furthermore, given the increasing interest in the interplay between the immune system and skin microbiota, Langerin's study may uncover new therapeutic avenues for maintaining skin health and combating dermal-related pathologies. Overall, ongoing research into Langerin/CD207 recombinant protein holds significant promise for advancing our understanding of immunology and therapeutic interventions in dermatological and systemic diseases.